On 14 December 2018, orphan designation (EU/3/18/2111) was granted by the European Commission to RHEACELL GmbH & Co. KG, Germany, for allogeneic ABCB5-positive limbal stem cells (also known as LSC2) for the treatment of limbal stem cell deficiency.
Allogeneic ABCB5-positive limbal stem cells
|Disease / condition||
Treatment of limbal stem cell deficiency
|Date of first decision||
|EU designation number||
Review of designation
Sponsor's contact details
For contact details of patients’ organisations whose activities are targeted at rare diseases, see:
European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.
- Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe;